Lidocain Hwi Pharma (Lidocaine)

Lidocaine blocks voltage‑gated sodium channels on nerve membranes, preventing the rapid influx of sodium ions needed for depolarisation. This stops the initiation and conduction of nerve impulses, resulting in reversible loss of sensation and pain relief at the site of application.

The appropriate dose is determined by the prescribing healthcare professional based on the specific procedure, patient age, weight, and clinical condition. Dosage instructions are provided on the product label and must be followed exactly as directed by the prescriber.

Safety data for rectal lidocaine in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any potential risk to the fetus or infant, and this decision must be made by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lidocaine is an amide‑type local anesthetic with a rapid onset and moderate duration of action. Compared with ester‑type agents such as procaine, lidocaine generally offers a more predictable pharmacokinetic profile, lower allergenic potential, and broader clinical use for both topical and injectable applications.

Lidocain Hwi Pharma should be stored at room temperature, below 25 °C, in its original container. Keep the product away from moisture, direct sunlight and extreme heat. Ensure the packaging remains sealed until use to maintain product integrity.

The product is applied rectally, typically as a gel, ointment or suppository, according to the prescribing information. The healthcare professional will clean the area, apply the appropriate amount, and allow the formulation to remain in place for the recommended contact time before proceeding with the procedure.

Serious risks include systemic toxicity leading to seizures, cardiac arrhythmias, or hypotension, especially if excessive amounts are absorbed. Rare but severe allergic reactions such as anaphylaxis and methemoglobinemia may also occur. Immediate medical attention is required if any of these symptoms develop.

Patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics should avoid this product. It is also contraindicated in individuals with severe cardiac conduction disorders, uncontrolled heart failure, or those taking medications that may cause dangerous interactions without close monitoring.